Literature DB >> 18475272

Heavy marijuana users show increased serum apolipoprotein C-III levels: evidence from proteomic analyses.

S Jayanthi1, S Buie, S Moore, R I Herning, W Better, N M Wilson, C Contoreggi, J L Cadet.   

Abstract

Marijuana (MJ) is the most commonly used illicit drug in the United States. Its abuse is associated with cognitive dysfunctions and increased resistance to blood flow in the cerebral vasculature. In addition, MJ abuse is associated with increased risks of potentially serious cardiovascular disorders. In the present study, we used the protein chip platform based on surface-enhanced laser desorption/ionization time-of-flight mass spectroscopy (SELDI-TOF-MS) to test the possibility that MJ abuse might be associated with changes in serum protein levels. Indeed, MJ users showed significant increases in three protein peaks, which were identified as three isoforms of apolipoprotein (apo) C-III. Immunoprecipitation using an apoC-III antibody also validated the identification of the proteins. Marijuana-induced increases in apoC-III levels might occur through chronic stimulation of hepatic cannabinoid receptors (CB1 and/or CB2) by its active ingredient, Delta(9)tetrahydrocannibol (THC). Thus, chronic MJ abuse might cause increased transcription and/or translation of apoC-III in the liver with corresponding changes reflected in the plasma of these patients. In any case, because apoC-III is a cardiovascular risk factor, the increased levels observed in MJ users might explain, in part, the cardiac and cerebral abnormalities reported in these patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18475272      PMCID: PMC2797551          DOI: 10.1038/mp.2008.50

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  66 in total

1.  Cerebrovascular disease associated with marijuana abuse: a case report.

Authors:  A Mesec; U Rot; A Grad
Journal:  Cerebrovasc Dis       Date:  2001       Impact factor: 2.762

2.  Dose-related neurocognitive effects of marijuana use.

Authors:  K I Bolla; K Brown; D Eldreth; K Tate; J L Cadet
Journal:  Neurology       Date:  2002-11-12       Impact factor: 9.910

Review 3.  Cardiovascular system effects of marijuana.

Authors:  Reese T Jones
Journal:  J Clin Pharmacol       Date:  2002-11       Impact factor: 3.126

4.  Marijuana abusers are at increased risk for stroke. Preliminary evidence from cerebrovascular perfusion data.

Authors:  R I Herning; W E Better; K Tate; J L Cadet
Journal:  Ann N Y Acad Sci       Date:  2001-06       Impact factor: 5.691

5.  Use of proteomic patterns in serum to identify ovarian cancer.

Authors:  Emanuel F Petricoin; Ali M Ardekani; Ben A Hitt; Peter J Levine; Vincent A Fusaro; Seth M Steinberg; Gordon B Mills; Charles Simone; David A Fishman; Elise C Kohn; Lance A Liotta
Journal:  Lancet       Date:  2002-02-16       Impact factor: 79.321

6.  Altered cannabinoid receptor mRNA expression in peripheral blood mononuclear cells from marijuana smokers.

Authors:  Liang Nong; Catherine Newton; Qingwen Cheng; Herman Friedman; Michael D Roth; Thomas W Klein
Journal:  J Neuroimmunol       Date:  2002-06       Impact factor: 3.478

7.  Cognitive functioning of long-term heavy cannabis users seeking treatment.

Authors:  Nadia Solowij; Robert S Stephens; Roger A Roffman; Thomas Babor; Ronald Kadden; Michael Miller; Kenneth Christiansen; Bonnie McRee; Janice Vendetti
Journal:  JAMA       Date:  2002-03-06       Impact factor: 56.272

8.  Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.

Authors:  Jinong Li; Zhen Zhang; Jason Rosenzweig; Young Y Wang; Daniel W Chan
Journal:  Clin Chem       Date:  2002-08       Impact factor: 8.327

9.  Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients.

Authors:  Yinsheng Qu; Bao-Ling Adam; Yutaka Yasui; Michael D Ward; Lisa H Cazares; Paul F Schellhammer; Ziding Feng; O John Semmes; George L Wright
Journal:  Clin Chem       Date:  2002-10       Impact factor: 8.327

10.  Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.

Authors:  Bao-Ling Adam; Yinsheng Qu; John W Davis; Michael D Ward; Mary Ann Clements; Lisa H Cazares; O John Semmes; Paul F Schellhammer; Yutaka Yasui; Ziding Feng; George L Wright
Journal:  Cancer Res       Date:  2002-07-01       Impact factor: 12.701

View more
  4 in total

1.  Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice.

Authors:  Douglas Osei-Hyiaman; Jie Liu; Liang Zhou; Grzegorz Godlewski; Judith Harvey-White; Won-il Jeong; Sándor Bátkai; Giovanni Marsicano; Beat Lutz; Christoph Buettner; George Kunos
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

Review 2.  Neuropathology of substance use disorders.

Authors:  Jean Lud Cadet; Veronica Bisagno; Christopher Mark Milroy
Journal:  Acta Neuropathol       Date:  2013-11-29       Impact factor: 17.088

3.  Characterization of the endocannabinoid system in human neuronal cells and proteomic analysis of anandamide-induced apoptosis.

Authors:  Nicoletta Pasquariello; Giuseppina Catanzaro; Valeria Marzano; Daniele Amadio; Daniela Barcaroli; Sergio Oddi; Giorgio Federici; Andrea Urbani; Alessandro Finazzi Agrò; Mauro Maccarrone
Journal:  J Biol Chem       Date:  2009-08-18       Impact factor: 5.157

4.  Cannabis Use Induces Distinctive Proteomic Alterations in Olfactory Neuroepithelial Cells of Schizophrenia Patients.

Authors:  Marta Barrera-Conde; Karina Ausin; Mercedes Lachén-Montes; Joaquín Fernández-Irigoyen; Liliana Galindo; Aida Cuenca-Royo; Cristina Fernández-Avilés; Víctor Pérez; Rafael de la Torre; Enrique Santamaría; Patricia Robledo
Journal:  J Pers Med       Date:  2021-02-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.